|
⚲
|
| Keyboard |
| Matthew Gonda | |
|---|---|
| Firm | |
| Address | 40 Burton Hills Boulevard Suite 200 Nashville, TN 37215 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Amytrx Therapeutics Inc | 021-504045 | Director | 0.7 M of 6.0 M |
||
| Amytrx Therapeutics Inc | 021-373104 | Executive Officer | 3.6 M of 12.0 M |
||
| Amytrx Therapeutics Inc | 021-294041 | Executive Officer | of 2.1 M |
||
| AGH Therapeutics Inc | 021-245020 | Executive Officer | 0.6 M of 4.5 M |
||
| Power Ten Medical Ventures I LP | 021-146448 | Director | 5.0 M of 25.0 M |
||
| Omnimmune Holdings Inc | 021-121906 | Director | 0.2 M of 0.5 M |
||